Foster Dykema Cabot & Partners, LLC Novartis Ag Transaction History
Foster Dykema Cabot & Partners, LLC
- $1.19 Trillion
- Q3 2024
A detailed history of Foster Dykema Cabot & Partners, LLC transactions in Novartis Ag stock. As of the latest transaction made, Foster Dykema Cabot & Partners, LLC holds 1,266 shares of NVS stock, worth $131,524. This represents 0.01% of its overall portfolio holdings.
Number of Shares
1,266
Previous 936
35.26%
Holding current value
$131,524
Previous $99.6 Million
46.13%
% of portfolio
0.01%
Previous 0.01%
Shares
2 transactions
Others Institutions Holding NVS
# of Institutions
1,433Shares Held
135MCall Options Held
1.47MPut Options Held
1.39M-
Dodge & Cox San Francisco, CA12.2MShares$1.27 Billion0.85% of portfolio
-
Primecap Management CO Pasadena, CA12MShares$1.25 Billion1.03% of portfolio
-
Dimensional Fund Advisors LP Austin, TX8.09MShares$841 Million0.23% of portfolio
-
Morgan Stanley New York, NY7.42MShares$771 Million0.06% of portfolio
-
Loomis Sayles & CO L P5.77MShares$599 Million0.87% of portfolio
About NOVARTIS AG
- Ticker NVS
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,151,000,064
- Market Cap $223B
- Description
- Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...